| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women QA Karim, SSA Karim, JA Frohlich, AC Grobler, C Baxter, LE Mansoor, ... science 329 (5996), 1168-1174, 2010 | 2697 | 2010 |
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies … GD Tomaras, NL Yates, P Liu, L Qin, GG Fouda, LL Chavez, AC Decamp, ... Journal of virology 82 (24), 12449-12463, 2008 | 552 | 2008 |
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env M Pancera, T Zhou, A Druz, IS Georgiev, C Soto, J Gorman, J Huang, ... Nature 514 (7523), 455, 2014 | 524 | 2014 |
| Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? L Stamatatos, L Morris, DR Burton, JR Mascola Nature medicine 15 (8), 866, 2009 | 494 | 2009 |
| Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies NA Doria-Rose, CA Schramm, J Gorman, PL Moore, JN Bhiman, ... Nature 509 (7498), 55, 2014 | 488 | 2014 |
| The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection ES Gray, MC Madiga, T Hermanus, PL Moore, CK Wibmer, NL Tumba, ... Journal of virology 85 (10), 4828-4840, 2011 | 422 | 2011 |
| Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors M Bonsignori, KK Hwang, X Chen, CY Tsao, L Morris, E Gray, DJ Marshall, ... Journal of virology 85 (19), 9998-10009, 2011 | 399 | 2011 |
| Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern … M Li, JF Salazar-Gonzalez, CA Derdeyn, L Morris, C Williamson, ... Journal of virology 80 (23), 11776-11790, 2006 | 374 | 2006 |
| Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ... PLoS medicine 2 (4), e112, 2005 | 361 | 2005 |
| Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C JM Binley, EA Lybarger, ET Crooks, MS Seaman, E Gray, KL Davis, ... Journal of virology 82 (23), 11651-11668, 2008 | 359 | 2008 |
| Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1 PL Moore, ET Crooks, L Porter, P Zhu, CS Cayanan, H Grise, P Corcoran, ... Journal of virology 80 (5), 2515-2528, 2006 | 345 | 2006 |
| Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection ES Gray, PL Moore, IA Choge, JM Decker, F Bibollet-Ruche, H Li, ... Journal of virology 81 (12), 6187-6196, 2007 | 343 | 2007 |
| Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140 A Trkola, TJ Ketas, KA Nagashima, L Zhao, T Cilliers, L Morris, JP Moore, ... Journal of virology 75 (2), 579-588, 2001 | 296 | 2001 |
| Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape PL Moore, ES Gray, CK Wibmer, JN Bhiman, M Nonyane, DJ Sheward, ... Nature medicine 18 (11), 1688, 2012 | 285 | 2012 |
| HIV-1 antigen–specific and–nonspecific B cell responses are sensitive to combination antiretroviral therapy L Morris, JM Binley, BA Clas, S Bonhoeffer, TP Astill, R Kost, A Hurley, ... Journal of Experimental Medicine 188 (2), 233-245, 1998 | 274 | 1998 |
| Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines JR Mascola, P D'Souza, P Gilbert, BH Hahn, NL Haigwood, L Morris, ... Journal of virology 79 (16), 10103-10107, 2005 | 266 | 2005 |
| Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated JA Johnson, J Li, L Morris, N Martinson, G Gray, J McIntyre, W Heneine The Journal of infectious diseases 192 (1), 16-23, 2005 | 239 | 2005 |
| Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection PL Moore, N Ranchobe, BE Lambson, ES Gray, E Cave, MR Abrahams, ... PLoS pathogens 5 (9), e1000598, 2009 | 222 | 2009 |
| Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1) K Yamada, C Andrews, WM Chan, CA McKeown, A Magli, ... Nature genetics 35 (4), 318, 2003 | 222 | 2003 |
| Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals GD Tomaras, JM Binley, ES Gray, ET Crooks, K Osawa, PL Moore, ... Journal of virology 85 (21), 11502-11519, 2011 | 201 | 2011 |
